1. 712PMolecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial. (23rd October 2018) Authors: O'Kane, G M; Fischer, S; Denroche, R E; Jang, G H; Zhang, A; Dodd, A; Albaba, H; Moura, S; Holter, S; Aung, K; Grant, R C; Krzyzanowski, P; Elimova, E; Dhani, N; Hedley, D; Notta, F; Wilson, J M; Gallinger, S; Knox, J J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. (2nd July 2019) Authors: Reni, M; Riess, H; O'Reilly, E; Santoro, A; Park, J; Bekaii-Saab, T; Tempero, M; Shan, Y; Macarulla, T; Cutsem, E Van; Noel, M; Berlin, J; Biankin, A; Dhani, N; Frassineti, G; Goldstein, D; Romano, A; Bruchec, Y Le; Philip, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗